Microfluidic Manufacture of Lipid-Based Nanomedicines

Microfluidic Manufacture of Lipid-Based Nanomedicines

Nanoparticulate technologies have revolutionized drug delivery allowing for passive and active targeting, altered biodistribution, controlled drug release (temporospatial or triggered), enhanced stability, improved solubilization capacity, and a reduction in dose and adverse effects. However, their...

Full description

Bibliographic Details
Main Authors: Karim Osouli-Bostanabad, Sara Puliga, Dolores R. Serrano, Andrea Bucchi, Gavin Halbert, Aikaterini Lalatsa
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Pharmaceutics
Subjects:
nanomedicine
microfluidics
liposomes
manufacture
engineering
scale-up
Online Access:https://www.mdpi.com/1999-4923/14/9/1940

Internet

https://www.mdpi.com/1999-4923/14/9/1940

Similar Items